CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 40 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 348,960 | $1,225,000 | 0.88% |
| PERKINS CAPITAL MANAGEMENT INC | 289,680 | $1,017,000 | 0.59% |
| Newbridge Financial Services Group, Inc. | 87,185 | $306,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 144,084 | $506,000 | 0.20% |
| Union Square Park Capital Management, LLC | 75,000 | $263,000 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $108,000 | 0.06% |
| Ikarian Capital, LLC | 219,109 | $769,000 | 0.03% |
| GAGNON SECURITIES LLC | 48,072 | $169,000 | 0.03% |
| SEGALL BRYANT & HAMILL, LLC | 703,826 | $2,475,000 | 0.02% |
| Phocas Financial Corp. | 30,000 | $105,000 | 0.01% |